trending Market Intelligence /marketintelligence/en/news-insights/trending/Yz8aNaR6-cSTbyNmzEMrWg2 content esgSubNav
In This List

Stereotaxis to list on NYSE American

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Stereotaxis to list on NYSE American

Stereotaxis Inc.'s common shares have been approved to list on the NYSE American, an exchange designed for growing companies.

The St. Louis-based healthcare technology company's common stock will continue trading on OTCQX until market close Sept. 5 and will begin trading on the NYSE American platform under its current symbol STXS on Sept. 6.